Spot the Difference: Acute vs. Subacute Cutaneous Lupus
Avery H. LaChance, MD, MPH, FAAD
Understanding Difficult-to-Treat Axial Spondyloarthritis in Real-World Practice
IL-23 Inhibitors Show Broad PsA Control, with Important Gaps Remaining
A Visual Guide to Cutaneous Dermatomyositis
The Next Era of Psoriatic Arthritis Management
Laura Coates, MBChB, MRCP, PhD
Measuring What Matters in Psoriatic Arthritis
Minimal Disease Activity: A Practical Target in Psoriatic Arthritis
Aligning Patient and Physician Perspectives in Psoriatic Arthritis
Unpacking the Complexity of Psoriatic Arthritis
Lawrence H. Brent
Shared CD8+ T Cell Clones Link Skin and Joint Inflammation in Psoriatic Arthritis
JAK Inhibitors in Psoriatic Arthritis: Reassessing Safety in the Real World
Can We Prevent Psoriatic Arthritis Before Diagnosis?
Rethinking SLE Treatment: Recent Approvals, Novel Targets, and What’s Next
Steve Jackson, PharmD
Marc Scherlinger, MD, PhD
Exploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
Gary S. Firestein, MD
Cadherin-6 in Focus: Existing Antibodies, Emerging Applications
TYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
Loading...
We're glad to see you're enjoying Rheumatology Academy… but how about a more personalized experience?
Press cancel to remain on Rheumatology Academy. Press the link below or the continue button to keep going.